Format

Send to

Choose Destination
Pediatr Clin North Am. 2012 Oct;59(5):1093-115. doi: 10.1016/j.pcl.2012.07.009. Epub 2012 Aug 22.

Pharmacotherapy of pediatric HIV infection.

Author information

1
Division of Infectious Diseases, Children's National Medical Center, Washington, DC 20010, USA. nrakhman@cnmc.org

Abstract

The delivery of safe and effective antiretroviral therapy to children and adolescents is crucial to save the lives of millions of children worldwide. The immunologic response to human immunodeficiency infection is closely related to a child's development and creates age-specific parameters for the evaluation of therapeutic response to antiretroviral therapy. Similarly, the development and maturation of organ systems involved in drug absorption, distribution, metabolism, and elimination determines significant changes in the pharmacokinetics of antiretroviral drugs throughout childhood. The authors review the evolution in treatment of pediatric HIV from infancy through adolescence.

PMID:
23036246
PMCID:
PMC3465562
DOI:
10.1016/j.pcl.2012.07.009
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center